[{"NetIncomeLoss_1_Q2_USD":-38714000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":10713000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-2000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":59669000.0,"Depreciation_2_Q2_USD":2086000.0,"Depreciation_1_Q2_USD":1400000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":809472.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":3008000.0,"AssetsCurrent_0_Q2_USD":290161000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":48662000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":33371753.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":3574791.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":114569000.0,"CommonStockSharesIssued_0_Q2_shares":25624730.0,"Assets_0_Q2_USD":350664000.0,"ShareBasedCompensation_2_Q2_USD":11113000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":11923000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9378478.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":52.82,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":843000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":3860000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":33350492.0,"GeneralAndAdministrativeExpense_1_Q2_USD":8649000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":16783000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":53661000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":30089000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":31.18,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":13485000.0,"InvestmentsAndCash_0_Q2_USD":301800000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":3323000.0,"ProceedsFromStockPlans_2_Q2_USD":405000.0,"CommonStockValue_0_Q2_USD":256000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":20389000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-86000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-70386000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-38730000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":3835000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":685000.0,"OtherAssetsNoncurrent_0_Q2_USD":831000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":246049000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9146000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":581056000.0,"Liabilities_0_Q2_USD":28208000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-28000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-16000.0,"OperatingLeaseLiability_0_Q2_USD":12642000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":12.33,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":733000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1573000.0,"CommonStockSharesAuthorized_0_Q2_shares":1000000000.0,"OperatingIncomeLoss_2_Q2_USD":-70444000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":4375000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":1015000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":5609000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-54614000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":3949000.0,"LiabilitiesCurrent_0_Q2_USD":19062000.0,"AccountsPayableCurrent_0_Q2_USD":4853000.0,"NonoperatingIncomeExpense_2_Q2_USD":86000.0,"NonoperatingIncomeExpense_1_Q2_USD":24000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8716000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":524000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":216000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.036,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":283000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":246049000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":84971.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":405000.0,"OperatingLeasePayments_2_Q2_USD":1614000.0,"OperatingLeasePayments_1_Q2_USD":853000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":814000.0,"DividendsCommonStock_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":27360000.0,"NetIncomeLoss_2_Q2_USD":-70358000.0,"CommonStockSharesOutstanding_0_Q2_shares":25624730.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":1935000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":4969000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":1785789.0,"OperatingIncomeLoss_1_Q2_USD":-38738000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":35396000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":87.58,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":7.69,"OperatingLeaseCost_2_Q2_USD":1741000.0,"OperatingLeaseCost_1_Q2_USD":955000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":350664000.0,"PreferredStockSharesAuthorized_0_Q2_shares":200000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":86396.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":31735000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3496000.0,"OperatingExpenses_2_Q2_USD":70444000.0,"OperatingExpenses_1_Q2_USD":38738000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-2.11,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.16,"ProfitLoss_2_Q2_USD":-70358000.0,"StockholdersEquity_0_Q2_USD":322456000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":9235000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-332000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3564665.0,"VariableLeaseCost_2_Q2_USD":137000.0,"VariableLeaseCost_1_Q2_USD":66000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-258918000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":1137000.0,"Ticker":"IGMS","CIK":"1496323","name":"IGM BIOSCIENCES, INC.","OfficialName":"IGM Biosciences Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"806397058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]